The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Niushko K.M.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Alekseev B.Ia.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Krasheninnikov A.A.

FGBU «Moskovskiĭ nauchno-issledovatelskiĭ onkologicheskiĭ institut im. P.A. Gertsena» Minzdrava Rossii

Vorob'ev N.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im P.A. Gertsena"

Safronova E.Yu.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Kalpinskiĭ A.S.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossiii

Sergienko S.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Taraki I.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Temirgereev M.Z.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Kaprin A.D.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Surgical treatment in patients with localized and locally advanced prostate cancer: results of a monocentric study

Authors:

Niushko K.M., Alekseev B.Ia., Krasheninnikov A.A., Vorob'ev N.V., Safronova E.Yu., Kalpinskiĭ A.S., Sergienko S.A., Taraki I.A., Temirgereev M.Z., Kaprin A.D.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2018;7(1): 4‑13

Read: 1362 times


To cite this article:

Niushko KM, Alekseev BIa, Krasheninnikov AA, et al. Surgical treatment in patients with localized and locally advanced prostate cancer: results of a monocentric study. P.A. Herzen Journal of Oncology. 2018;7(1):4‑13. (In Russ.)
https://doi.org/10.17116/onkolog2018714-13

Recommended articles:
Venous factor in surgical mana­gement of skull base meni­ngiomas. Burdenko's Journal of Neurosurgery. 2025;(2):97-103
Therapeutic options in patients with neuralgic amyotrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):39-45
Peri­neal endo­metriosis after deli­very: causes of deve­lopment, treatment, prevention. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):79-83

References:

  1. Kaprin AD, Starinskii VV, Petrova GV, eds. Zlokachestvennye novoobrazovaniya v Rossii v 2015 (zabolevaemost’ i smertnost’). Moscow: MNIOI im. P.A. Gertsena — filial FGBU «NMIRTs» Minzdrava Rossii; 2017. (In Russ.)
  2. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R; EUROCARE-5 Working Group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol. 2014;15(1):23-34. https://doi.org/10.1016/S1470-2045(13)70546-1
  3. Jansson KF, Akre O, Garmo H, Bill-Axelson A, Adolfsson J, Stattin P, Bratt O. Concordance of tumor differentiation among brothers with prostate cancer. Eur Urol. 2012;62(4):656-661. https://doi.org/10.1016/j.eururo.2012.02.032
  4. Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, Nordling S, Häggman M, Andersson SO, Spångberg A, Andrén O, Palmgren J, Steineck G, Adami HO, Johansson JE. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014;370(10):932-942. https://doi.org/10.1056/NEJMoa1311593
  5. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol. 1993;150(2,Pt1):379-385. https://doi.org/10.1016/S0022-5347(17)35487-3
  6. Dahm P, Yang B, Salmen C, Moul J, Gan T. Radical perineal prostatectomy for the treatment of localized prostate cancer in morbidly obese patients. J Urol. 2005;174(1):131-134. https://doi.org/10.1097/01.ju.0000161593.29525.e2
  7. Paiva C, Andreoni C, Cunha G, Khalil W, Ortiz V. Differences among patients undergoing perineal or retropubic radical prostatectomy in pain and perioperative variables: a prospective study. BJU Int. 2009;104(9):1219-1226. https://doi.org/10.1111/j.1464-410x.2009.08551.x
  8. Fichtner J, Gillitzer R, Melchior S. Perineal complications following radical perineal prostatectomy. Aktuelle Urol. 2003;34(4):223-225. https://doi.org/10.1055/s-2003-41599
  9. Lassen PM, Kearse WS. Rectal injuries during radical perineal prostatectomy. Urology. 1995;45:266-269. https://doi.org/10.1016/0090-4295(95)80016-6
  10. Alekseev BYa, Nyushko KM, Kalpinskii AS, Krasheninnikov AA, Vorob’ev NV, Sergienko SA, Kaprin AD. Radical perineal prostatectomy in patients with prostate cancer: methodological aspects and results. Onkologiya. Zhurnal im. P.A. Gertsena. 2016;5(1):5-11. (In Russ.) https://doi.org/10.17116/onkolog2016515-11
  11. Jansson KF, Akre O, Garmo H, Bill-Axelson A, Adolfsson J, Stattin P, Bratt O. Oncologic outcome after laparoscopic radical prostatectomy: 10 years of experience. Eur Urol. 2009;55(5):1014-1019. https://doi.org/10.1016/j.eururo.2008.10.036
  12. Magheli A, Gonzalgo ML, Su LM, Guzzo TJ, Netto G, Humphreys EB, Han M, Partin AW, Pavlovich CP. Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching. BJU Int. 2011;107(12):1956-1962. https://doi.org/10.1111/j.1464-410X.2010.09795.x
  13. Ramsay C, Pickard R, Robertson C, Close A, Vale L, Armstrong N, Barocas DA, Eden CG, Fraser C, Gurung T, Jenkinson D, Jia X, Lam TB, Mowatt G, Neal DE, Robinson MC, Royle J, Rushton SP, Sharma P, Shirley MD, Soomro N. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess. 2012;16(41):1-313. https://doi.org/10.3310/hta16410
  14. Prostate cancer: diagnosis and treatment. Cardiff (UK): National Collaborating Centre for Cancer (UK); 2014 Jan. NICE Clinical Guidelines, No. 175. https://www.ncbi.nlm.nih.gov/books/NBK247469/?report=reader
  15. Asimakopoulos AD, Pereira Fraga CT, Annino F, Pasqualetti P, Calado AA, Mugnier C. Randomized comparison between laparoscopic and robot-assisted nerve-sparing radical prostatectomy. J Sex Med. 2011;8(5):1503-1512. https://doi.org/10.1111/j.1743-6109.2011.02215.x
  16. Berge V, Berg RE, Hoff JR, Wessel N, Diep LM, Karlsen SJ, Eri LM. A prospective study of transition from laparoscopic to robot-assisted radical prostatectomy: quality of life outcomes after 36-month follow-up. Urology. 2013;81(4):781-786. https://doi.org/10.1016/j.urology.2013.01.017
  17. Cristian Fiori, Ivano Morra, Francesca Ragni, Susanna Grande, Marco Lucci Chiarissi, Fabrizio Mele, Massimiliano Poggio, Francesco Porpiglia. 1130 pure versus robot-assisted laparoscopic prostatectomy single center, single surgeon experience. J Urol. 2012;187(4,Suppl.):e458. https://doi.org/10.1016/j.juro.2012.02.1239
  18. Wolanski P, Chabert C, Jones L, Mullavey T, Walsh S, Gianduzzo T. Preliminary results of robot-assisted laparoscopic radical prostatectomy (RALP) after fellowship training and experience in laparoscopic radical prostatectomy (LRP). BJU Int. 2012;110(Suppl.4):64-70. https://doi.org/10.1111/j.1464-410X.2012.11479.x
  19. Hoskin PJ, Rojas AM, Ostler PJ, Hughes R, Lowe GJ, Bryant L. Quality of life after radical radiotherapy for prostate cancer: longitudinal study from a randomised trial of external beam radiotherapy alone or in combination with high dose rate brachytherapy. Clin Oncol. 2013;25(5):321-327. https://doi.org/10.1016/j.clon.2013.01.001
  20. Joseph JV, Vicente I, Madeb R, Erturk E, Patel HR. Robot-assisted vs pure laparoscopic radical prostatectomy: are there any differences? BJU Int. 2005;96(1):39-42. https://doi.org/10.1111/j.1464-410X.2005.05563.x
  21. Willis DL, Gonzalgo ML, Brotzman M, Feng Z, Trock B, Su LM. Comparison of outcomes between pure laparoscopic vs robot-assisted laparoscopic radical prostatectomy: a study of comparative effectiveness based upon validated quality of life outcomes. BJU Int. 2012;109(6):898-905. https://doi.org/10.1111/j.1464-410X.2011.10551.x
  22. Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE). J. Urol. 2005;173(5):1557-1561. https://doi.org/10.1097/01.ju.0000154610.81916.81
  23. Cooperberg MR, Carroll PR. Trends in management for patients with localized prostate cancer. 1990—2013. JAMA. 2015;314(1):80-2. https://doi.org/10.1001/jama.2015.6036
  24. Freedland SJ, Partin AW, Humphreys EB, Mangold LA, Walsh PC. Radical prostatectomy for clinical stage T3a disease. Cancer. 2007;109(7):1273-1278. https://doi.org/10.1002/cncr.22544
  25. Akre O, Garmo H, Adolfsson J, Lambe M, Bratt O, Stattin P. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden. Eur Urol. 2011;60(3):554-563. https://doi.org/10.1016/j.eururo.2011.05.047
  26. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int. 2005;95(6):751-756. https://doi.org/10.1111/j.1464-410X.2005.05394.x
  27. Yossepowitch O, Eggener SE, Serio AM, Carver BS, Bianco FJ Jr, Scardino PT, Eastham JA. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. Eur. Urol. 2008;53(5):950-959. https://doi.org/10.1016/j.eururo.2007.10.008
  28. Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ Jr, Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol. 2009;27(26):4300-4305. https://doi.org/10.1200/JCO.2008.18.2501
  29. Mitchell CR, Boorjian SA, Umbreit EC, Rangel LJ, Carlson RE, Karnes RJ. 20-year survival after radical prostatectomy as initial treatment for cT3 prostate cancer. BJU Int. 2012;110(11):1709-1713. https://doi.org/10.1111/j.1464-410X.2012.11372.x
  30. Briganti A, Karnes RJ, Gandaglia G, Spahn M, Gontero P, Tosco L. Natural history of surgically treated high-risk prostate cancer. Urol Oncol. 2015;33(4):163.e7-13. https://doi.org/10.1016/j.urolonc.2014.11.018

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.